Haoxiangni Health Food Co.,Ltd. (SHE:002582)
China · Delayed Price · Currency is CNY 11.18
+0.27 (2.47%)
May 29, 2026, 3:04 PM CST
Haoxiangni Health Food Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Operating Revenue | 1,375 | 1,279 | 1,581 | 1,673 | 1,340 | 1,235 |
Other Revenue | 48.28 | 48.28 | 58.77 | 54.86 | 60.29 | 46.41 |
| 1,423 | 1,328 | 1,640 | 1,728 | 1,400 | 1,281 | |
Revenue Growth (YoY) | -8.55% | -19.03% | -5.12% | 23.40% | 9.32% | -57.32% |
Cost of Revenue | 1,008 | 956.01 | 1,273 | 1,285 | 1,150 | 955.49 |
Gross Profit | 414.54 | 371.77 | 366.88 | 443.66 | 250.72 | 325.63 |
Selling, General & Admin | 423.6 | 398.95 | 461.87 | 495.43 | 433.04 | 370.07 |
Research & Development | 19 | 19.78 | 20.64 | 28.57 | 38.65 | 34.19 |
Other Operating Expenses | 5.22 | 5.14 | 5.06 | 2.95 | 14.16 | 14.88 |
Operating Expenses | 452.4 | 428.45 | 493.42 | 531.09 | 517.61 | 420.65 |
Operating Income | -37.86 | -56.68 | -126.54 | -87.44 | -266.89 | -95.02 |
Interest Expense | -22.91 | -22.91 | -26.68 | -18.5 | -13.58 | -15.82 |
Interest & Investment Income | 25.18 | 29.64 | 92.67 | 49.81 | 55.3 | 75.46 |
Currency Exchange Gain (Loss) | -0.01 | -0.01 | -0.01 | - | - | 0.11 |
Other Non Operating Income (Expenses) | -4.66 | -0.74 | -0.75 | -0.79 | -0.67 | -0.65 |
EBT Excluding Unusual Items | -40.26 | -50.7 | -61.31 | -56.92 | -225.84 | -35.92 |
Gain (Loss) on Sale of Investments | 2,633 | 1,221 | -8.69 | -1.46 | -0.74 | 79.61 |
Gain (Loss) on Sale of Assets | -1.89 | -1.54 | -4.53 | -0.33 | 0.01 | 1.3 |
Asset Writedown | -24.12 | -26.07 | -5.75 | -2.94 | -29.44 | -8.69 |
Other Unusual Items | 1.43 | 1.43 | 4.83 | 10.87 | 21.86 | 30.38 |
Pretax Income | 2,569 | 1,144 | -75.44 | -50.78 | -234.17 | 66.68 |
Income Tax Expense | 631.58 | 278.75 | 0.27 | 5.76 | -31.32 | 11.75 |
Earnings From Continuing Operations | 1,937 | 865.22 | -75.71 | -56.54 | -202.85 | 54.93 |
Minority Interest in Earnings | 0.45 | 0.86 | 3.76 | 4.64 | 13.43 | 6.7 |
Net Income | 1,937 | 866.08 | -71.96 | -51.89 | -189.42 | 61.63 |
Net Income to Common | 1,937 | 866.08 | -71.96 | -51.89 | -189.42 | 61.63 |
Net Income Growth | - | - | - | - | - | -97.14% |
Shares Outstanding (Basic) | 434 | 433 | 450 | 432 | 441 | 474 |
Shares Outstanding (Diluted) | 434 | 433 | 450 | 432 | 441 | 474 |
Shares Change (YoY) | -4.59% | -3.71% | 4.00% | -1.83% | -7.09% | -5.62% |
EPS (Basic) | 4.46 | 2.00 | -0.16 | -0.12 | -0.43 | 0.13 |
EPS (Diluted) | 4.46 | 2.00 | -0.16 | -0.12 | -0.43 | 0.13 |
EPS Growth | - | - | - | - | - | -96.97% |
Free Cash Flow | -7.14 | -2.39 | -37.98 | 343.67 | -278.78 | -124.7 |
Free Cash Flow Per Share | -0.02 | -0.01 | -0.08 | 0.80 | -0.63 | -0.26 |
Dividend Per Share | 0.600 | 0.600 | 1.400 | 0.600 | 0.100 | 0.100 |
Dividend Growth | -57.14% | -57.14% | 133.33% | 500.00% | - | -90.00% |
Gross Margin | 29.13% | 28.00% | 22.37% | 25.67% | 17.90% | 25.42% |
Operating Margin | -2.66% | -4.27% | -7.72% | -5.06% | -19.06% | -7.42% |
Profit Margin | 136.15% | 65.23% | -4.39% | -3.00% | -13.53% | 4.81% |
Free Cash Flow Margin | -0.50% | -0.18% | -2.32% | 19.89% | -19.91% | -9.73% |
EBITDA | 78.7 | 59.05 | -14.13 | 24.78 | -150.58 | 12.74 |
EBITDA Margin | 5.53% | 4.45% | -0.86% | 1.43% | -10.75% | 1.00% |
D&A For EBITDA | 116.56 | 115.73 | 112.41 | 112.21 | 116.31 | 107.76 |
EBIT | -37.86 | -56.68 | -126.54 | -87.44 | -266.89 | -95.02 |
EBIT Margin | -2.66% | -4.27% | -7.72% | -5.06% | -19.06% | -7.42% |
Effective Tax Rate | 24.59% | 24.37% | - | - | - | 17.62% |
Revenue as Reported | 1,328 | 1,328 | 1,640 | 1,728 | 1,400 | 1,281 |
Advertising Expenses | - | 105.46 | 136.62 | 146.85 | 122.89 | 88.13 |